HTA - 13/81/02

RCT of clinical and cost-effectiveness of drug coated balloons, drug eluting stents and balloon angioplasty with bail-out bare metal stent revascularisation strategies for severe limb ischaemia due to femoro-popliteal disease: BASIL-3 (Balloon vs Stenting in Severe Ischaemia of the Leg)

Project title: RCT of clinical and cost-effectiveness of drug coated balloons, drug eluting stents and balloon angioplasty with bail-out bare metal stent revascularisation strategies for severe limb ischaemia due to femoro-popliteal disease: BASIL-3 (Balloon vs Stenting in Severe Ischaemia of the Leg)

Call to action: 13/81 13/81 The clinical and cost effectiveness of new minimally invasive treatments for patients with critical limb ischaemia

Research type: Primary Research

Chief investigator: Professor Andrew Bradbury

Contractor: University of Birmingham

Cost: £1,631,230.72

Co-investigators: Dr Allan Odurny, Dr Arul Ganeshan, Dr Jai Patel, Dr Lazaros Andronis, Dr Margaret Grant, Dr Nick Burfitt, Dr Ralph Jackson, Dr Raman Uberoi, Dr Reddi Yadavali, Dr Trevor Cleveland, Dr Will Adair, Mr Hugh Jarrett, Mr Jeremy Perkins, Mr Martin Claridge, Mr Wesley Stuart, Mrs Smitaa Patel, Professor Alun Davies, Professor Anna-Maria Belli, Professor Cliff Shearman, Professor Duncan Ettles, Professor Gerard Stansby, Professor Ian Chetter, Professor Jon Moss, Professor Jonathan Beard, Professor Jonathan Deeks, Professor Julian Scott, Professor Julie Brittenden, Professor Robert Hinchliffe, Professor Ross Naylor.

Started: August 2015 | Status: Research in progress

ISRCTN: 14469736

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.